Filing Details
- Accession Number:
- 0001209191-22-015819
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-03 18:09:56
- Reporting Period:
- 2022-03-01
- Accepted Time:
- 2022-03-03 18:09:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1515673 | Ultragenyx Pharmaceutical Inc. | RARE | Pharmaceutical Preparations (2834) | 272546083 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1603347 | Alan Theodore Huizenga | C/O Ultragenyx Pharmaceutical Inc. 60 Leveroni Court Novato CA 94949 | Svp, Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-03-01 | 843 | $66.62 | 13,229 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2022-03-01 | 3,710 | $0.00 | 17,046 | No | 4 | A | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | A | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2022-03-01 | 7,400 | $0.00 | 7,400 | $67.37 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
7,400 | 2032-03-01 | No | 4 | A | Direct |
Footnotes
- Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").
- Award of RSUs under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.
- Includes 107 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 29, 2021.
- Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
- On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.